Cancer as a Metabolic Disease
Over time, numerous theories have emerged to explain cancer’s origins. Currently, the Somatic Mutation Theory (SMT) dominates conventional oncology, attributing cancer to inherited or random mutations in DNA, particularly in key “driver genes.” The US National Cancer Institute supports this view, defining cancer as a genetic disease.
Research shows that contrary to typical cell energy production through oxidative phosphorylation (electron transport by using oxygen) in mitochondria, cancer cells often rely on glucose fermentation even in oxygen-rich environments. This metabolic phenomenon, observed by Otto Warburg in 1927, is known as the “Warburg effect.” Cancer cells exhibit an extraordinarily high glucose consumption—up to 200 times that of normal cells—fueling rapid growth with excessive lactic acid production.
Initially overshadowed by the Somatic Mutation Theory, Warburg’s findings gained renewed attention recently, sparking interest in cancer as a mitochondrial metabolic disease. Studies, including Hanahan and Weinberg’s 2011 Hallmarks of Cancer, highlight how cancer cells modify their metabolism to sustain growth, emphasizing the Warburg effect.
Further challenging the Somatic Mutation Theory, research such as Seyfried’s 2015 study on mitochondrial metabolic disease underscores that cancer may stem more from mitochondrial damage than nuclear DNA mutations. Nuclear-cytoplasmic transfer experiments indicated that the cytoplasm’s origin, whether from tumor cells or normal cells, crucially determines tumor formation. This metabolic perspective strengthens the argument for cancer as a disease of altered cell metabolism preceding genetic mutations.
What Damages the Mitochondria
In the past two centuries, significant changes to our environment—air, water, and soil—have reduced our adaptability and flexibility to cope with modern pressures. This impacts our metabolic systems and mitochondrial health, contributing to disease and the cancer process.
Conventional cancer treatment focuses on tumors and typically involves combinations of chemotherapy, radiation, and medication, all of which can themselves cause cancer (carcinogenic). These treatments not only target cancer cells but also harm healthy cells, weaken the immune system, damage DNA, disrupt gut microbes, and promote inflammation and oxidative damage—factors known to promote cancer. Moreover, they fail to address mitochondrial damage.
As early as 2008, researchers at the Anderson Cancer Center linked 90–95% of cancer cases to poor diet and unhealthy lifestyles that impair mitochondrial function.
Recently, the 2019 Global Burden of Disease study examined modifiable risk factors contributing to cancer-related disability and death. Environmental and occupational exposures, behavioral factors, and metabolic influences collectively accounted for a substantial burden of disease-adjusted life years (DALYs) and mortality, underscoring the need for targeted interventions to mitigate these risks.
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
Based on the findings of these research groups, which emphasize that a significant portion of cancer risk factors can be modified, it is evident that treatment strategies must extend beyond targeting the tumor alone. To effectively eradicate cancer cells, we need to enhance mitochondrial function and the body’s natural healing mechanisms. This involves identifying the underlying factors triggering the onset of cancer and addressing the overall biological environment, not just the tumor, through appropriate therapies tailored to mitochondrial requirements.
What is the Metabolic Approach
At Blatman Health and Wellness Center, we evaluate ten main drivers that impact mitochondrial health as identified by Metabolic Terrain Institute for Health (MTIH), and by extension, metabolic health, which MTIH calls the Terrain Ten™.
- Modifying Genetic, Epigenetic, and Nutrigenomic expression
- Balancing blood sugar
- Minimizing Toxic burden
- Repopulating and balancing the microbiome
- Modulating immune system function
- Lowering inflammation and oxidative stress
- Enhancing blood circulation while inhibiting angiogenesis and metastasis
- Establishing hormone balance
- Re-calibrating stress levels and biorhythms
- Improving mental and emotional well-being
The Metabolic Approach to Cancer diagnosis and treatment emphasize a holistic perspective. The factors contributing to the disease process differ among individuals, making personalized clinical care essential. It values and acknowledges each person’s unique bio-individuality and medical history. By identifying and treating the root causes of disease, the aim is to improve both quality of life and treatment outcomes. The objective is to collaborate with your body’s natural processes rather than working in opposition to them.
More Reading on Understanding Cancer as a Metabolic Disease
You can learn more about the metabolic approach to cancer and read success stories below:
- Provocative Question: Should Ketogenic Metabolic Therapy Become-Abstract only
- Metabolic Oncology Exploration Understanding
- Local Regional Treatment of Hepatocellular Carcinoma A Primer for Radiologists PubMed
- Management of Glioblastoma
- Metabolically Supported Chemotherapy for Managing End Stage Breast Cancer A Complete and Durable Response
- Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer
- Can the Mitochondrial Metabolic Theory Explain Better the Origin and Management of Cancer than Can the Somatic Mutation Theory
- Fasting and Cancer
Visit https://www2.mtih.org/research#intro for even more case studies and to learn about other therapeutic treatments that are beneficial to cancer patients.
Testimonial
In 2013 Alison was diagnosed with a terminal malignant brain cancer with an average survival time of 6.8 months. As of this interview in 2023, Alison is thriving after adopting the Metabolic Approach to Cancer, Health & Life. Watch the interview below.
Treating Cancer with the Metabolic Approach at Blatman Health and Wellness
Dr. Blatman, our founder and medical director, recently added onto his skillset and graduated from The Metabolic Approach to Cancer program at the Metabolic Terrain Institute of Health, led by Dr. Nasha Winters, ND, FABNO. Through this course, Dr. Blatman enhanced his knowledge of personalized nutrition, therapeutic diets, and integrative strategies that support metabolic resilience and optimize well-being. If you are someone suffering from cancer and would like a new approach to treatment, please schedule an appointment with us today to get started.